Weiye Li MD, PhD
Professor Emeritus of Ophthalmology, Drexel University College of Medicine, Philadelphia, Pennsylvania; Physician, Drexel Eye Physicians, Philadelphia, PennsylvaniaDr. Weiye Li is an Emeritus Professor of Ophthalmology at Drexel University College of Medicine. He served as the Director of both Ophthalmic Research and Retina Services at Drexel.
Dr. Weiye Li received his medical degree from the Second Medical College of Beijing, China, and received his doctorate from the University of Pennsylvania in Philadelphia. He completed a fellowship in retina vitreous diseases at Crozer-Chester Medical Center, Upland, Pennsylvania. Dr. Li was previously Chairman of the Department of Ophthalmology at Peking Union Medical College Hospital, one of the most competitive and internationally respected medical colleges in the People's Republic of China.
Dr. Li’s basic and clinical research focuses on diabetic retinopathy and age-related macular degeneration He is widely published in the field of ophthalmology and has earned many honors and awards for his research. He is also active in many organizations, including the Association of Research in Vision and Ophthalmology.
Recent Contributions to PracticeUpdate:
- Visual Loss in Geographic Atrophy
- 2024 Top Story in Eye Care: Faricimab and Gene Therapy in Retinal Diseases
- Novel Agents in the Management of Diabetes and the Risk of Worsening Diabetic Retinopathy
- Features of Pachy-Reticular Pseudodrusen
- Visual Acuity and Visual Field as a Function of Disease Duration in Patients With Birdshot Chorioretinitis
- Utility of an Abbreviated Variation of the Steamroller Maneuver After Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment
- Outcomes of Vitrectomy With and Without Internal Limiting Membrane Peeling in Small Idiopathic Macular Holes
- Prevalence, Features, and Risk Factors of Macular Retinoschisis in a Population With High Myopia
- Safety and Efficacy of Subthreshold Micropulse Yellow Laser for Persistent Subretinal Fluid After Scleral Buckling
- Outcomes of Conversion to Faricimab After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Oedema